These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
400 related items for PubMed ID: 8283037
1. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. Smith CI, Baskin B, Humire-Greiff P, Zhou JN, Olsson PG, Maniar HS, Kjellén P, Lambris JD, Christensson B, Hammarström L. J Immunol; 1994 Jan 15; 152(2):557-65. PubMed ID: 8283037 [Abstract] [Full Text] [Related]
2. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. de Weers M, Verschuren MC, Kraakman ME, Mensink RG, Schuurman RK, van Dongen JJ, Hendriks RW. Eur J Immunol; 1993 Dec 15; 23(12):3109-14. PubMed ID: 8258324 [Abstract] [Full Text] [Related]
3. Expression of Bruton's tyrosine kinase protein within the B cell lineage. Genevier HC, Hinshelwood S, Gaspar HB, Rigley KP, Brown D, Saeland S, Rousset F, Levinsky RJ, Callard RE, Kinnon C. Eur J Immunol; 1994 Dec 15; 24(12):3100-5. PubMed ID: 7805739 [Abstract] [Full Text] [Related]
5. Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members. Müller S, Sideras P, Smith CI, Xanthopoulos KG. Oncogene; 1996 Nov 07; 13(9):1955-64. PubMed ID: 8934542 [Abstract] [Full Text] [Related]
10. BTK mutations in patients with X-linked agammaglobulinemia: lack of correlation between presence of peripheral B lymphocytes and specific mutations. Tao L, Boyd M, Gonye G, Malone B, Schwaber J. Hum Mutat; 2000 Dec 07; 16(6):528-9. PubMed ID: 11102984 [Abstract] [Full Text] [Related]
11. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes. Pérez de Diego R, López-Granados E, Pozo M, Rodríguez C, Sabina P, Ferreira A, Fontan G, García-Rodríguez MC, Alemany S. J Allergy Clin Immunol; 2006 Jun 07; 117(6):1462-9. PubMed ID: 16751014 [Abstract] [Full Text] [Related]
14. Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region. Maas A, Dingjan GM, Grosveld F, Hendriks RW. J Immunol; 1999 Jun 01; 162(11):6526-33. PubMed ID: 10352268 [Abstract] [Full Text] [Related]
17. Bruton's tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia. Yip KL, Chan SY, Ip WK, Lau YL. Hum Mutat; 2000 Apr 01; 15(4):385. PubMed ID: 10737994 [Abstract] [Full Text] [Related]
18. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). Zhu Q, Zhang M, Rawlings DJ, Vihinen M, Hagemann T, Saffran DC, Kwan SP, Nilsson L, Smith CI, Witte ON, Chen SH, Ochs HD. J Exp Med; 1994 Aug 01; 180(2):461-70. PubMed ID: 7519238 [Abstract] [Full Text] [Related]
19. Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia. Vorechovský I, Luo L, Hertz JM, Frøland SS, Klemola T, Fiorini M, Quinti I, Paganelli R, Ozsahin H, Hammarström L, Webster AD, Smith CI. Hum Mutat; 1997 Aug 01; 9(5):418-25. PubMed ID: 9143921 [Abstract] [Full Text] [Related]